Format

Send to

Choose Destination
Eur Cytokine Netw. 2009 Dec;20(4):158-63. doi: 10.1684/ecn.2009.0170.

VEGF-A: a critical regulator of blood vessel growth.

Author information

1
Genentech, Inc., San Francisco, CA 94080, USA. nf@gene.com

Abstract

Angiogenesis is required for a variety of normal and pathological, proliferative processes. Numerous regulators of angiogenesis have been identified and characterized over the last decades. Among these, vascular endothelial growth factor (VEGF)-A appears especially important in normal development and in disease processes. Several VEGF inhibitors have been approved by the FDA for the treatment of tumors or the neovascular form of age-related macular degeneration. This article examines the molecular and biological characteristics of VEGF and also discusses preclinical and clinical studies with VEGF inhibitors and the lessons learned from these studies.

PMID:
20167554
DOI:
10.1684/ecn.2009.0170
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for John Libbey Eurotext
Loading ...
Support Center